| # | Drug | Count |
|---|---|---|
| 0 | PAZOPANIB HYDROCHLORIDE | 7 |
| 1 | ESTRADIOL | 6 |
| 2 | ESTRADIOL GEL 0.1% | 6 |
| 3 | ESTRADIOL TRANSDERMAL | 6 |
| 4 | ESTRADIOL, | 6 |
| 5 | PROGESTERONE | 6 |
| 6 | LETROZOLE | 4 |
| 7 | LETROZOLE TABLETS | 4 |
| 8 | LEUPROLIDE ACETATE | 4 |
| 9 | PACLITAXEL | 4 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TOREMIFENE CITRATE | 2 | 0.0046 |
| 1 | DEXRAZOXANE FOR INJECTION | 2 | 0.0021 |
| 2 | TRABECTEDIN | 2 | 0.0009 |
| 3 | ERDAFITINIB | 1 | 0.0008 |
| 4 | MEGESTROL ACETATE | 2 | 0.0005 |
| 5 | DACARBAZINE | 2 | 0.0003 |
| 6 | PAZOPANIB HYDROCHLORIDE | 7 | 0.0003 |
| 7 | PROGESTERONE | 6 | 0.0003 |
| 8 | IFOSFAMIDE FOR INJECTION | 3 | 0.0001 |
| 9 | ANASTROZOLE TABLETS | 3 | 0.0001 |
| # | Drug class | Count |
|---|---|---|
| 0 | Aromatase Inhibitor [EPC] | 7 |
| 1 | Estrogen [EPC] | 6 |
| 2 | Microtubule Inhibitor [EPC] | 6 |
| 3 | Progesterone [EPC] | 6 |
| 4 | Kinase Inhibitor [EPC] | 5 |
| 5 | Alkylating Drug [EPC] | 3 |
| 6 | Progestin [EPC] | 3 |
| 7 | Progestin-containing Intrauterine System [EPC] | 3 |
| 8 | Tumor Necrosis Factor Blocker [EPC] | 3 |
| 9 | Angiotensin 2 Receptor Blocker [EPC] | 2 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 1 | Progesterone [EPC] | 6 | 0.0003 |
| 2 | Aromatase Inhibitor [EPC] | 7 | 0.0001 |
| 3 | Microtubule Inhibitor [EPC] | 6 | 0.0000 |
| 4 | Estrogen [EPC] | 6 | 0.0000 |
| 5 | Estrogen Receptor Antagonist [EPC] | 1 | 0.0000 |
| 6 | Selective T Cell Costimulation Modulator [EPC] | 2 | 0.0000 |
| 7 | Alkylating Drug [EPC] | 3 | 0.0000 |
| 8 | Progestin [EPC] | 3 | 0.0000 |
| 9 | Purine Antimetabolite [EPC] | 1 | 0.0000 |